Search Results

There are 2045 results for: content related to: Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

  1. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

    Clinical & Experimental Allergy

    Volume 45, Issue 5, May 2015, Pages: 928–939, L. Orivuori, K. Mustonen, M. C. de Goffau, S. Hakala, M. Paasela, C. Roduit, J.-C. Dalphin, J. Genuneit, R. Lauener, J. Riedler, J. Weber, E. von Mutius, J. Pekkanen, H. J. M. Harmsen, O. Vaarala and the PASTURE Study Group

    Article first published online : 16 APR 2015, DOI: 10.1111/cea.12522

  2. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 12, Issue 6, June 2006, Pages: 524–534, Michael R. Konikoff and Lee A. Denson

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200606000-00013

  3. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1406–1412, Keisuke Inoue, Tomoki Aomatsu, Atsushi Yoden, Takeru Okuhira, Emiri Kaji and Hiroshi Tamai

    Article first published online : 15 JUL 2014, DOI: 10.1111/jgh.12578

  4. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1493–1497, Ron Shaoul, Marlgozata Sladek, Dan Turner, Anders Paeregaard, Gabor Veres, Gigi Veereman Wauters, Johanna Escher, Jorge Amil Dias, Paolo Lionetti, Annamaria Staino, Kaija Leena Kolho, Lissy de Ridder, Federica Nuti, Salvatore Cucchiara, Orit Sheva, Arie Levine and and the ESPGHAN Porto IBD Group

    Article first published online : 24 JAN 2012, DOI: 10.1002/ibd.21875

  5. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies

    Inflammatory Bowel Diseases

    Volume 18, Issue 10, October 2012, Pages: 1894–1899, Ren Mao, Ying-lian Xiao, Xiang Gao, Bai-li Chen, Yao He, Li Yang, Pin-jin Hu and Min-hu Chen

    Article first published online : 11 JAN 2012, DOI: 10.1002/ibd.22861

  6. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Article first published online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  7. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2018–2025, Patrick F. van Rheenen

    Article first published online : 24 JAN 2012, DOI: 10.1002/ibd.22896

  8. Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 549–558, T. Yamamoto, T. Shimoyama and K. Matsumoto

    Article first published online : 3 JUL 2015, DOI: 10.1111/apt.13308

  9. Serum Calprotectin More Accurately Discriminates the Inflammatory Disease Activity of Rheumatoid Arthritis Patients Receiving TNF inhibitors than Acute Phase Reactants

    Arthritis Care & Research

    Accepted manuscript online: 25 NOV 2015, José Inciarte-Mundo, Maria Victoria Hernández, Virginia Ruiz-Esquide, Sonia Raquel Cabrera-Villalba, Julio Ramirez, Andrea Cuervo, Mariona Pascal, Jordi Yagüe, Juan D Cañete and Raimon Sanmarti

    DOI: 10.1002/acr.22795

  10. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children

    Acta Paediatrica

    Volume 91, Issue 1, January 2002, Pages: 45–50, E Olafsdottir, L Aksnes, G Fluge and A Berstad

    Article first published online : 2 JAN 2007, DOI: 10.1111/j.1651-2227.2002.tb01638.x

  11. You have free access to this content
    Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

    Journal of Internal Medicine

    Volume 270, Issue 1, July 2011, Pages: 50–57, K. Andréasson, A. Scheja, T. Saxne, B. Ohlsson and R. Hesselstrand

    Article first published online : 9 JAN 2011, DOI: 10.1111/j.1365-2796.2010.02340.x

  12. Calprotectin levels in meconium

    Acta Paediatrica

    Volume 92, Issue 4, April 2003, Pages: 463–466, N Laforgia, ME Baldassarre, G Pontrelli, F Indrio, MA Altomare, G Di Bitonto and A Mautone

    Article first published online : 2 JAN 2007, DOI: 10.1111/j.1651-2227.2003.tb00579.x

  13. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Article first published online : 5 NOV 2015, DOI: 10.1002/art.39448

  14. Mucosal healing in Crohn's disease: A systematic review

    Inflammatory Bowel Diseases

    Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen and Greg Moore

    Article first published online : 26 APR 2012, DOI: 10.1002/ibd.22977

  15. You have free access to this content
    Anti-Candida Activity of Cal protect in in Combination with Neutrophils or Lactoferrin

    Microbiology and Immunology

    Volume 42, Issue 11, November 1998, Pages: 789–793, Takafumi Okutomi, Takashi Tanaka, Satoru Yui, Masaaki Mikami, Masatoshi Yamazaki, Shigeru Abe and Hideyo Yamaguchi

    Article first published online : 14 NOV 2013, DOI: 10.1111/j.1348-0421.1998.tb02353.x

  16. Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1470–1479, Asit Parikh, Timothy Leach, Tim Wyant, Catherine Scholz, Serap Sankoh, Diane R. Mould, Terry Ponich, Irving Fox and Brian G. Feagan

    Article first published online : 6 DEC 2011, DOI: 10.1002/ibd.21896

  17. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: A clue to the increased risk of intestinal malignancy in adulthood?

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 5, May 2015, Pages: 866–871, Tamara Pang, Steven T Leach, Tamarah Katz, Adam Jaffe, Andrew S Day and Chee Y Ooi

    Article first published online : 10 APR 2015, DOI: 10.1111/jgh.12842

  18. Plasma calprotectin: A new prognostic marker of survival in alcohol-induced cirrhosis

    Hepatology

    Volume 21, Issue 4, April 1995, Pages: 979–985, Christian Homann, Peter Garred, Niels Graudal, Philip Hasselqvist, Michael Christiansen, Magne K. Fagerhol and Åge Christian Thomsen

    Article first published online : 9 DEC 2005, DOI: 10.1002/hep.1840210415

  19. Detection of calprotectin and its correlation to the accumulation of neutrophils within equine large colon during ischaemia and reperfusion

    Equine Veterinary Journal

    Volume 40, Issue 4, June 2008, Pages: 393–399, A. GROSCHEt, A. J. MORTON, M. M. R. POLYAK, S. MATYJASZEK and D. E. FREEMAN

    Article first published online : 5 JAN 2010, DOI: 10.2746/042516408X302500

  20. You have free access to this content
    Poster Presentations by Authors from A-Z (alphabetical order)

    Neurogastroenterology & Motility

    Volume 27, Issue S2, June 2015, Pages: 37–109,

    Article first published online : 31 MAY 2015, DOI: 10.1111/nmo.12598